---
title: Cedars-Sinai invests in Neolook – first US institutional investor
description: Neolook Solutions secures USD 525.000 from Cedars-Sinai Medical Center via Post-Money SAFE at a USD 7.5M valuation cap – the first US institutional investment in Neolook, with a linked Milestone Equity Agreement tied to clinical trial, health economics, and FDA readiness.
---

[blog](https://www.neolooksolutions.com/blog)

# [Cedars-Sinai invests in Neolook – first US institutional investor](https://www.neolooksolutions.com/blog/cedars-sinai-medical-center-invests-in-neolook-solutions-first-us-institutional-investor)

 Written by [Marco D'Agata](https://www.neolooksolutions.com/blog/author/marco-dagata) | 11 November 2025

Neolook Solutions B.V., the Dutch neonatal digital health company, has secured USD 525.000 from Cedars-Sinai Medical Center (Los Angeles, California) via a Post-Money SAFE at a USD 7,5 million valuation cap. The investment constitutes Neolook Round 3 and makes Cedars-Sinai the first US institutional investor in the company.

The commitment is the direct outcome of a structured three-track international expansion programme executed by Neolook across 2024 and 2025. In the Middle East, Neolook was selected as 1 of 6 startups for the Anjal Z Techstars Founder Catalyst programme (Cohort 05) from 264 global applicants, backed by the Abu Dhabi Early Childhood Authority. In Southeast Asia, Neolook activated a market entry track via Invest International, the Dutch government's internationalisation instrument. In the United States, the ScaleNL programme created the institutional pipeline that led directly to the Cedars-Sinai relationship.

The investment is structured as a Post-Money SAFE with a 20 % discount and includes a linked Milestone Equity Agreement. The milestone equity component grants Cedars-Sinai additional rights conditional on three deliverables: a clinical trial, a health economic study and a demonstrated FDA readiness pathway. Cedars-Sinai becomes Neolook's first US reference site and a co-development partner on the clinical and regulatory evidence required for US market entry.

[View full post](https://www.neolooksolutions.com/blog/cedars-sinai-medical-center-invests-in-neolook-solutions-first-us-institutional-investor)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Marco D'Agata"
  },
  "dateModified" : "2026-04-25T06:27:27.236Z",
  "datePublished" : "2025-11-11T10:00:00Z",
  "headline" : "Cedars-Sinai invests in Neolook – first US institutional investor",
  "image" : {
    "@type" : "ImageObject",
    "height" : 1306,
    "url" : "https://7435642.fs1.hubspotusercontent-na1.net/hubfs/7435642/Neolook%20Logo%20Large%20FC%201160x263.png",
    "width" : 2320
  },
  "mainEntityOfPage" : "https://www.neolooksolutions.com/blog/cedars-sinai-medical-center-invests-in-neolook-solutions-first-us-institutional-investor",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "blog"
  }
}
```